United Medical College Hospital
Tracked across 2 events · 12 articles · First seen Aug 31, 2026 · Last active Sep 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Insilico Medicine announced on September 9-10, 2026 that it has dosed the first patient with Rentosertib (ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial for idiopathic pulmonary fibrosis (IPF), at United Medical College…
Impact: United Medical College Hospital is the site where the first patient was dosed and is led by the trial's Leading Principal Investigator, Professor Zuojun Xu. Its involvement underscores its role in advancing clinical research for IPF.
Sep 10, 2026 · 6 articles
Tech
Impact: The hospital where the surgeries were performed, benefiting from the milestone and associated publicity.
Aug 31, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United Medical College Hospital live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard